We are live on
!
Find out more
Puma Biotechnology
PBYI
PBYI
163 hedge funds and large institutions have $2.27B invested in Puma Biotechnology in 2015 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 66 increasing their positions, 56 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
438% more call options, than puts
Call options by funds: $149M | Put options by funds: $27.6M
18% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 56
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.4% less ownership
Funds ownership: 94.72% → 93.32% (-1.4%)
18% less funds holding
Funds holding: 198 → 163 (-35)
36% less capital invested
Capital invested by funds: $3.55B → $2.27B (-$1.28B)
72% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 47
Holders
163
Holders Change
-35
Holders Change %
-17.68%
% of All Funds
4.55%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
13
Increased
66
Reduced
56
Closed
47
Calls
$149M
Puts
$27.6M
Net Calls
+$121M
Net Calls Change
+$122M
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$45.9M |
| 2 |
O
OrbiMed
New York
|
+$24.1M |
| 3 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$23.6M |
| 4 |
T
TOBAM
Paris,
France
|
+$22.6M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$20.3M |
